Gaurav Maini
Stock Analyst at LifeSci Capital
(4.14)
# 1,494
Out of 4,501 analysts
30
Total ratings
100%
Success rate
30.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TENX Tenax Therapeutics | Maintained: Buy | $27 → $35 | $17.55 | +99.43% | 6 | Jul 6, 2026 | |
| SION Sionna Therapeutics | Maintained: Buy | $60 | $45.29 | +32.48% | 10 | Jun 22, 2026 | |
| TECX Tectonic Therapeutic | Rated: Buy | $88 | $34.37 | +156.04% | 7 | Jun 10, 2026 | |
| LQDA Liquidia | Maintained: Buy | $71 | $77.93 | -8.89% | 3 | May 16, 2026 | |
| IKT Inhibikase Therapeutics | Maintained: Buy | $5 | $2.04 | +145.10% | 4 | May 16, 2026 |
Tenax Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $27 → $35
Current: $17.55
Upside: +99.43%
Sionna Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $60
Current: $45.29
Upside: +32.48%
Tectonic Therapeutic
Jun 10, 2026
Rated: Buy
Price Target: $88
Current: $34.37
Upside: +156.04%
Liquidia
May 16, 2026
Maintained: Buy
Price Target: $71
Current: $77.93
Upside: -8.89%
Inhibikase Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.04
Upside: +145.10%